Charles Schwab Investment Management Inc. decreased its position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 1.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,633,877 shares of the health services provider's stock after selling 22,443 shares during the period. Charles Schwab Investment Management Inc. owned 1.27% of Select Medical worth $27,286,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. GAMMA Investing LLC boosted its holdings in shares of Select Medical by 217.4% in the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock valued at $109,000 after purchasing an additional 4,453 shares during the period. Lazard Asset Management LLC boosted its holdings in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after purchasing an additional 2,255 shares during the period. Wealthquest Corp purchased a new stake in shares of Select Medical in the first quarter valued at approximately $143,000. Quarry LP boosted its holdings in shares of Select Medical by 963.0% in the fourth quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after purchasing an additional 8,224 shares during the period. Finally, Vista Finance LLC boosted its holdings in shares of Select Medical by 7.0% in the first quarter. Vista Finance LLC now owns 10,969 shares of the health services provider's stock valued at $183,000 after purchasing an additional 716 shares during the period. Hedge funds and other institutional investors own 89.48% of the company's stock.
Select Medical Stock Down 1.8%
Select Medical stock traded down $0.2450 during mid-day trading on Monday, reaching $13.1750. 831,561 shares of the company were exchanged, compared to its average volume of 1,278,481. The business has a fifty day moving average of $14.00 and a 200 day moving average of $15.64. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The firm has a market cap of $1.63 billion, a P/E ratio of 12.43, a PEG ratio of 0.55 and a beta of 1.25. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Research analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.
Select Medical Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th will be given a $0.0625 dividend. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.9%. Select Medical's dividend payout ratio (DPR) is presently 23.58%.
Select Medical announced that its board has authorized a share buyback program on Thursday, May 1st that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the health services provider to buy up to 42.6% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. UBS Group reiterated a "neutral" rating and issued a $14.00 price target (down previously from $15.00) on shares of Select Medical in a report on Monday, August 4th. Royal Bank Of Canada lowered their target price on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, Select Medical presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.25.
Read Our Latest Stock Analysis on Select Medical
About Select Medical
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Further Reading

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.